← All companiesSSUPERNUS PHARMACEUTICALS, INC.
SUPN - CIK 0001356576
SUPERNUS PHARMACEUTICALS, INC. net income by year
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported net income of -$38.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
SUPN annual net income
SUPN net income 2011-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$38.60M | -152.2% |
| FY 2024 | $73.90M | +5584.6% |
| FY 2023 | $1.30M | -97.9% |
| FY 2022 | $60.70M | +13.7% |
| FY 2021 | $53.40M | -57.9% |
| FY 2020 | $126.95M | +12.3% |
| FY 2019 | $113.06M | +1.9% |
| FY 2018 | $110.99M | +93.8% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does SUPERNUS PHARMACEUTICALS, INC. make?
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported net income of -$38.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has SUPERNUS PHARMACEUTICALS, INC.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, SUPERNUS PHARMACEUTICALS, INC.'s net income declined from $53.81M to -$38.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.